EUVIMEDEUVIMED entdecken
Crossref

CILNIDIPINE: A NOVEL APPROACH TO HYPERTENSION AND COMORBID CONDITIONS

Gulafsha Chaudhary, Khushi Sharma, Dr. Prof. Ehtasamul Haque

Journal of Advanced Pharmaceutical Sciences and Natural Products · 19.01.2026 · 1 (1)

DOI: 10.66079/q772vh43 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Pharmaceutical Sciences and Natural Products, online erschienen am 19.01.2026. Verfasst von Gulafsha Chaudhary und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A prospective treatment for hypertension and related comorbidities, Cilnidipine is a fourth-generation dihydropyridine calcium channel blocker with a unique dual action on L-type and N-type calcium channels. Unlike traditional calcium channel blockers, it effectively lowers blood pressure without triggering reflex tachycardia. Additionally, its ability to inhibit excessive sympathetic activity provides significant organ-protective benefits, including reduced proteinuria, improved renal function, and enhanced insulin sensitivity. People with diabetes, metabolic syndrome, or chronic kidney disease will benefit most from this medication. Clinical research has shown that, in comparison to other calcium channel blockers like amlodipine, it is effective in reducing peripheral edema, lowering blood pressure, and improving tolerability. In addition to hypertension, cilnidipine has neuroprotective and stress-relieving properties and may be used to treat problems like congestive heart failure, neurological diseases, osteoporosis, and atherosclerosis. Its advantageous pharmacological profile, which includes better glucose management, enhanced lipid metabolism, and decreased oxidative stress, emphasizes how versatile it is as a therapeutic agent. Recent studies also point to its uses in cancer and pain treatment, highlighting its wide-ranging effectiveness. Although cilnidipine's dual-channel blocking makes it a better choice for long-term cardiovascular and systemic protection, more extensive research is required to completely determine its clinical usefulness in a range of patient types. Overall, this study suggested that cilnidipine stands out as a multifaceted therapeutic option with significant implications for long- term cardiovascular and systemic health.

Zitieren

APA

Chaudhary, G., Sharma, K., & Haque, D. P. E. (2026). CILNIDIPINE: A NOVEL APPROACH TO HYPERTENSION AND COMORBID CONDITIONS. Journal of Advanced Pharmaceutical Sciences and Natural Products, 1(1). https://doi.org/10.66079/q772vh43

Vancouver

Chaudhary G, Sharma K, Haque DPE. CILNIDIPINE: A NOVEL APPROACH TO HYPERTENSION AND COMORBID CONDITIONS. Journal of Advanced Pharmaceutical Sciences and Natural Products. 2026;1(1). doi:10.66079/q772vh43

BibTeX
@article{Chaudhary2026,
  author = {Chaudhary, Gulafsha and Sharma, Khushi and Haque, Dr. Prof. Ehtasamul},
  title = {CILNIDIPINE: A NOVEL APPROACH TO HYPERTENSION AND COMORBID CONDITIONS},
  journal = {Journal of Advanced Pharmaceutical Sciences and Natural Products},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.66079/q772vh43}
}
Kostenlos starten →